
Private equity on the ropes: when assets turn sour

Recent weeks have brought their fair share of high-profile portfolio companies going under - putting private equity in the spotlight once again. Kenny Wastell looks at five deals gone wrong
Latest News
Riverside carves out HealthTech BioActives from Ferrer
Deal includes three manufacturing facilities located in Spain, which employ around 140 staff
Capvis buys Tertianum Group
GP acquired the care home group from Swiss Prime Site and will be the company's sole shareholder
Iris Capital, Idinvest et al. inject $12.3m into Yubo
Iris, Idinvest and historical backers invest in the manager of the eponymous social media app
Mérieux Equity Partners backs Addmedica
GP uses its Mérieux Participations 3 fund, which held a first close on €200m in 2018
Back to Top